Einsatz von Cisatracurium bei Patienten mit Myasthenia gravis zur thorakoskopischen Thymektomie (VATT).

DOI: 10.36210/BerMedJ/epub1102019

Authors

  • Olaf Schedler Oskar Ziethen Krankenhaus Berlin; Klinik für Anästhesiologie; Chefarzt: Prof. Dr. med. G. Zietz, Fanninger Strasse 32, 10365 Berlin https://orcid.org/0000-0002-4465-524X
  • Dirk Grebe
  • Joerg Werner
  • Matthias Tittel
  • Gerhard Zietz

Abstract

The disruption of neuromuscular transmission at the motor end plate requires the reduced use of muscle relaxants in patients with myasthenia gravis (MG). Due to its special pharmacokinetics (Hofmann elimination), cisatracurium can induce more controllable anesthetic conditions in patients with MG.

Anaesthesiemanagement VATT

Downloads

Published

2019-01-02 — Updated on 2019-06-14

How to Cite

Schedler, O., Grebe, D., Werner, J., Tittel, M., & Zietz, G. (2019). Einsatz von Cisatracurium bei Patienten mit Myasthenia gravis zur thorakoskopischen Thymektomie (VATT).: DOI: 10.36210/BerMedJ/epub1102019. Berlin Medical Journal, 1(1). Retrieved from https://www.bmjs.me/index.php/BMJ/article/view/36

Issue

Vol. 1 No. 1 (2019): BerMedJ-Berlin Medical Journal

Section

original

License

Copyright (c) 2019 Olaf Schedler, Dirk Grebe, Joerg Werner, Matthias Tittel, Gerhard Zietz

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 > >>